1. Home
  2. SNDX vs TMP Comparison

SNDX vs TMP Comparison

Compare SNDX & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • TMP
  • Stock Information
  • Founded
  • SNDX 2005
  • TMP 1836
  • Country
  • SNDX United States
  • TMP United States
  • Employees
  • SNDX N/A
  • TMP N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • TMP Major Banks
  • Sector
  • SNDX Health Care
  • TMP Finance
  • Exchange
  • SNDX Nasdaq
  • TMP Nasdaq
  • Market Cap
  • SNDX 1.2B
  • TMP 985.0M
  • IPO Year
  • SNDX 2016
  • TMP N/A
  • Fundamental
  • Price
  • SNDX $13.18
  • TMP $63.21
  • Analyst Decision
  • SNDX Strong Buy
  • TMP Buy
  • Analyst Count
  • SNDX 10
  • TMP 2
  • Target Price
  • SNDX $36.20
  • TMP $69.00
  • AVG Volume (30 Days)
  • SNDX 1.8M
  • TMP 57.0K
  • Earning Date
  • SNDX 03-03-2025
  • TMP 04-25-2025
  • Dividend Yield
  • SNDX N/A
  • TMP 3.88%
  • EPS Growth
  • SNDX N/A
  • TMP 653.03
  • EPS
  • SNDX N/A
  • TMP 4.97
  • Revenue
  • SNDX $23,680,000.00
  • TMP $292,618,000.00
  • Revenue This Year
  • SNDX $274.86
  • TMP $12.86
  • Revenue Next Year
  • SNDX $130.47
  • TMP $7.68
  • P/E Ratio
  • SNDX N/A
  • TMP $13.00
  • Revenue Growth
  • SNDX N/A
  • TMP 35.84
  • 52 Week Low
  • SNDX $12.06
  • TMP $43.09
  • 52 Week High
  • SNDX $25.07
  • TMP $79.01
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 43.83
  • TMP 38.16
  • Support Level
  • SNDX $12.70
  • TMP $63.43
  • Resistance Level
  • SNDX $14.29
  • TMP $65.74
  • Average True Range (ATR)
  • SNDX 0.66
  • TMP 1.71
  • MACD
  • SNDX 0.03
  • TMP 0.12
  • Stochastic Oscillator
  • SNDX 45.32
  • TMP 35.29

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.

Share on Social Networks: